GSK3A and melanoma: This interaction has functional consequences, since in contrast to the situation in neural crest development where activation of WNT signaling results in expression of SOX10 [12], activation of WNT signaling by inhibiting the negative regulator GSK3α/β pharmacologically using different compounds potently suppresses SOX10 in primary melanoma cultures.